Drug
desferrioxamine
desferrioxamine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph phase_3
1
33%
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (33.3%)
Phase 21 (33.3%)
Phase 31 (33.3%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedearly_phase_1
Modulation of Cerebral Blood Flow Using Iron Chelators
NCT01365104
completedphase_3
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
NCT00350662
completedphase_2
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
NCT00349453
Clinical Trials (3)
Showing 3 of 3 trials
NCT01365104Early Phase 1
Modulation of Cerebral Blood Flow Using Iron Chelators
NCT00350662Phase 3
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
NCT00349453Phase 2
Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3